T

    Trinity Biotech plc (TRIB)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.77
    +0.09 (+0.93%)

    Market Cap: $7.87M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(16/37)
    Avg Surprise
    -887.25%
    PeriodReportedEst.SurpriseB/MYoY
    Dec 25
    		$-0.90$-0.32-181.25%Miss+96.6%
    Sep 25
    		$-0.40$0.00N/AMiss+96.9%
    Jun 25
    		$-14.40$-17.10+15.79%Beat-2.9%
    Mar 25
    		$-1.24$-0.05-2380.00%Miss+65.4%
    Dec 24
    		$-26.35$-9.00-192.75%Miss-14955.5%
    Sep 24
    		$-12.77$-16.20+21.17%Beat+57.6%
    Jun 24
    		$-14.00$-19.50+28.21%Beat+43.5%
    Mar 24
    		$-3.59$-0.12-2890.67%Miss-5881.3%
    Dec 23
    		$-0.17$-0.14-25.00%Miss+99.4%
    Sep 23
    		$-30.12$-13.50-123.11%Miss-291.2%
    Jun 23
    		$-24.78$-9.00-175.33%Miss-82500.0%
    Mar 23
    		$-0.06$-0.06+0.00%Beat+99.5%
    Dec 22
    		$-27.75$-9.00-208.33%Miss-46150.0%
    Sep 22
    		$-7.70$-6.00-28.33%Miss-182.8%
    Jun 22
    		$-0.03$-0.03+0.00%Beat-100.1%
    Mar 22
    		$-11.73$-6.00-95.50%Miss-11830.0%
    Dec 21
    		$-0.06$0.07-185.71%Miss-100.1%
    Sep 21
    		$9.30$12.00-22.50%Miss-82.7%
    Jun 21
    		$30.45$10.50+190.00%Beat+663.9%
    Mar 21
    		$0.10$0.07+42.86%Beat+88.7%
    Dec 20
    		$53.85$21.00+156.43%Beat+298.9%
    Sep 20
    		$53.70$15.00+258.00%Beat+7060.0%
    Jun 20
    		$-5.40$-0.02-26900.00%Miss-13600.0%
    Mar 20
    		$0.05$0.03+76.67%Beat-92.9%
    Dec 19
    		$13.50$9.00+50.00%Beat+19185.7%
    Sep 19
    		$0.75N/A-91.67%Miss-61.5%
    Jun 19
    		$0.04$0.07-42.86%Miss-99.1%
    Mar 19
    		$0.75N/A-92.86%Miss-85.3%
    Dec 18
    		$0.07$0.04+75.00%Beat-12.5%
    Sep 18
    		$1.95N/A-78.33%Miss-80.2%
    Jun 18
    		$4.35N/A-51.67%Miss-6.5%
    Mar 18
    		$5.10$7.50-32.00%Miss+332.2%
    Dec 17
    		$0.08$0.07+14.29%Beat-63.6%
    Sep 17
    		$9.85$8.50+15.88%Beat-27.0%
    Jun 17
    		$4.65$7.50-38.00%Miss-
    Mar 17
    		$1.18N/A-73.78%Miss-
    Dec 16
    		$0.22N/A+127.50%Beat-
    Sep 16
    		$13.50$12.30+9.76%Beat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-0.02EV/EBITDA-6.06x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-85.40%Operating Margin-9.98%
    ROE-1913.00%ROIC-24.38%
    Financial Health
    Debt/Equity-1.54xInterest Coverage-0.30x
    Current Ratio0.25xQuick Ratio0.12x
    Trading Statistics
    Beta0.99Avg Volume30.49K
    52-Week High$14.1752-Week Low$0.31

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.34
    SMA 20$11.11
    SMA 50$11.15
    SMA 200$19.70
    EMA 10$10.24
    EMA 20$10.73
    EMA 50$12.13
    EMA 200$18.11

    MACD

    Line: -0.60Signal: -0.46Hist: -0.15

    ADX

    ADX: 42.5+DI: 12.8-DI: 7.7

    Aroon & PSAR

    Aroon Up12.0
    Aroon DownN/A
    PSAR$12.61

    Bollinger Bands

    Upper Band$13.44
    Lower Band$8.78
    %B Position4191%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    40.9

    Momentum Oscillators

    Stoch %K8.8
    Stoch %D5.7
    Williams %R-87.9
    ROC (10d)-12.5%
    Momentum-1.40
    CCI (20d)-105.4
    MFI (14d)36.6

    Volatility Measures

    ATR (14d)$2.63(27.0%)
    StdDev (20d)1.16
    Hist Vol94.0%(High)

    Volume Flow

    VWAP$9.83
    OBV406.6M
    AD Line117.4B
    CMF (20d)-0.183

    Volume Metrics

    Avg Vol (20d)31.7K
    Vol Ratio0.5x(Low)
    VWMA (20d)$11.53

    Pivot Points

    R3$10.44
    R2$10.13
    R1$9.91
    Pivot Point$9.60
    S1$9.38
    S2$9.07
    S3$8.84

    Advanced Oscillators

    TSI-13.05
    Ultimate Osc31.2
    KST-54.71

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$11.06M$11.06M$14.25M$10.98M$7.58M$15.86M$15.15M$15.84M$14.70M$14.70M$14.68M$13.90M
    Cost of Revenue$7.52M$7.52M$8.16M$6.65M$6.01M$10.98M$9.84M$10.11M$9.71M$9.71M$10.40M$8.87M
    Gross Profit$3.55M$3.55M$6.09M$4.33M$1.57M$4.88M$5.31M$5.73M$5.00M$5.00M$4.28M$5.03M
    Operating Expenses$6.49M$6.49M$6.62M$7.37M$6.30M$16.39M$7.87M$17.51M$8.06M$8.06M$8.78M$9.07M
    R&D$1.06M$1.06M$813,311$646,537$1.12M$1.45M$1.01M$991,000$1.09M$1.09M$1.17M$1.23M
    SG&A$0$5.43M$0$6.73M$0$8.37M$6.52M$6.42M$7.50M$6.93M$7.68M$7.91M
    Operating Income$-2,942,818$-2,942,818$-536,566$-3,043,185$-4,732,535$-11,514,000$-2,558,000$-1,667,000$-3,041,000$-3,070,000$-4,500,000$-14,852,000
    Interest Income$0$-999$0$0$0$903,000$848,000$0$55,000$605,000$389,000$62,000
    Interest Expense$12.66M$12.66M$4.27M$2.15M$2.31M$4.28M$3.08M$5.42M$264,000$264,000$2.39M$3.82M
    Income Before Tax$-17,636,926$-17,636,926$-5,039,143$-5,748,914$-8,797,572$-15,798,000$-4,794,000$-6,888,000$-3,250,000$-3,250,000$-6,498,000$-18,613,000
    Income Tax Expense$-173,871$-173,871$72,670$297,934$0$585,000$-35,000$0$67,000$67,000$222,000$-267,000
    Net Income$-17,463,055$-17,463,055$-5,111,814$-6,046,849$-8,803,576$-16,956,000$-4,759,000$-6,757,000$-3,317,000$-3,317,000$-6,721,000$-5,988,000
    EBITDA$-2,214,358$-2,214,358$120,453$-2,377,394$-4,094,059$-9,598,000$-1,112,000N/A$-2,295,000$-2,295,000$-3,882,000$-14,306,000
    EBIT$-2,942,818$-2,942,818$-536,566$-3,043,185$-4,732,535$-10,022,000$-1,710,000N/A$-2,986,000$-2,986,000$-4,111,000$-14,790,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TRIB

    News

    Trinity Biotech (NASDAQ: TRIB) ends $25M standby share deal

    Trinity Biotech (NASDAQ: TRIB) has terminated its $25 million standby equity purchase agreement with YA II PN, LTD., leading to the deregistration of 675,048,580 ordinary shares (represented by 1,125,081 ADSs) that remained unsold. This follows an ADS ratio change on July 24, 2026, where one ADS now represents 600 ordinary shares, effectively a one-for-thirty reverse ADS split. The original registration covered 705,659,320 Class A ordinary shares.

    Stock Titan•8/21/26•
    Neutral

    Trinity Biotech (TRIB) makes AI data-center cooling push

    Trinity Biotech (TRIB) has announced that its subsidiary, Trinovium, is partnering with Echelon Data Centres to develop advanced liquid cooling solutions for AI and high-density computing infrastructure. This collaboration aims to address the increasing thermal management challenges in next-generation data centers, leveraging Trinovium's expertise in fluid manufacturing and analytics with Echelon's hyperscale data center experience. The liquid cooling market for data centers is projected to grow significantly, from $4 billion in 2026 to $27 billion by 2033, indicating a substantial opportunity for Trinovium's solutions, which also include a data-driven platform for monitoring coolant health.

    Stock Titan•8/17/26•
    Bullish

    Echelon’s More Than 700 MW in Development Gets a Cooling Collaborator

    Trinity Biotech's Trinovium subsidiary has partnered with Echelon Data Centres to develop advanced liquid cooling solutions for AI and high-density computing infrastructure. The collaboration aims to combine Trinovium's expertise in ultra-high-purity fluid manufacturing with Echelon's hyperscale data center portfolio, which includes over 700 MW under development. Initial efforts will focus on direct-to-chip cooling fluids and thermal management systems, addressing the growing demand for efficient cooling in AI-driven data centers, a market projected to reach $27 billion by 2033.

    Stock Titan•8/17/26•
    Bullish

    Trinity Biotech secures $7m from Perceptive Advisors

    Trinity Biotech (NASDAQ:TRIB) has secured an additional $7 million investment from its largest financial investor, Perceptive Advisors. This funding, comprising $2.5 million in new debt and $4.5 million in capitalized interest, will support the company's CGM+ continuous glucose monitoring platform, Trinovium subsidiary, and diagnostics business. Trinity Biotech also announced it has regained compliance with Nasdaq's minimum bid price requirement.

    Investing.com•8/15/26•
    Bullish

    Trinity Biotech secures $7m from Perceptive Advisors By Investing.com

    Trinity Biotech (NASDAQ:TRIB) has received an additional $7.0 million investment from its largest financial investor, Perceptive Advisors. This funding, comprising new debt and capitalized interest, will support the company's CGM+ continuous glucose monitoring platform, Trinovium subsidiary, and diagnostics business. The company also announced it has regained compliance with Nasdaq's minimum bid price requirement.

    Investing.com Nigeria•8/14/26•
    Bullish

    Frequently Asked Questions About TRIB

    Does TRIB pay dividends?
    Trinity Biotech plc (TRIB) has a dividend payment track record. See the TRIB dividend history page for its current payment status, yield, and streaks.
    What is TRIB's market cap?
    Trinity Biotech plc (TRIB) has a market capitalization of $7.87M with a current stock price of $9.77.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In